Redgrave P, Rodriguez M, Smith Y, et al. Goal-directed and habitual control in the basal ganglia: implications for Parkinsons disease.Nat RevNeurosci. 2010;11(11):760-772. doi:10.1038/nrn2915 January 17, 2022 Read More
SauerbierA,SchragA, Martinez-Martin P, et al. Dietary Variations in a Multiethnic Parkinsons Disease Cohort and Possible Influences on Nonmotor Aspects: A Cross-SectionalMulticentreStudy.ParkinsonsDis. 2018;2018:1-9. doi:10.1155/2018/7274085 January 17, 2022 Read More
ScheperjansF,DerkinderenP,BorghammerP. The Gut and Parkinsons Disease: Hype or Hope?BrundinP, Langston JW,BloemBR, eds.JParkinsonsDis. 2018;8(s1):S31-S39. doi:10.3233/JPD-181477 January 17, 2022 Read More
Simon DK, Tanner CM,BrundinP. Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. ClinGeriatrMed. 2020;36(1):1-12. January 17, 2022 Read More
Day JO, Mullin S. The genetics ofParkinson’sdisease and implications for clinical practice.Genes (Basel). 2021;12(7). doi:10.3390/genes12071006 January 17, 2022 Read More
Dorsey ER, Sherer T, Okun MS,BloemBR. The Emerging Evidence of the Parkinson Pandemic.BrundinP, Langston JW,BloemBR, eds.JParkinsonsDis. 2018;8(s1):S3-S8. doi:10.3233/JPD-181474 January 17, 2022 Read More
Goetz CG. The history of Parkinson’s disease: early clinical descriptions and neurological therapies.Cold SpringHarbPerspectMed. 2011;1(1):a008862. doi:10.1101/cshperspect.a008862 January 17, 2022 Read More
Greenland JC, Williams-Gray CH, Barker RA. The clinical heterogeneity of Parkinson’s disease and its therapeutic implications.?Eur JNeurosci. 2019;49(3):328-338. doi:10.1111/ejn.14094 January 17, 2022 Read More
Hoehn MM,YahrMD. Parkinsonism: onset, progression, and mortality.Neurology.1967;17:427-442. January 17, 2022 Read More
Johnson ME,StecherB,LabrieV,BrundinL,BrundinP. Triggers, Facilitators, and Aggravators: Redefining Parkinsons Disease Pathogenesis.TrendsNeurosci. 2019;42(1):4-13. doi:10.1016/j.tins.2018.09.007 January 17, 2022 Read More
